Iterum Therapeutics plc

Iterum Therapeutics plc

ITRM · Nasdaq

Iterum Therapeutics plc (ITRM) is a Biotechnology company in the Healthcare sector, listed on Nasdaq. This page provides the complete earnings calendar, dividend schedule, and financial data for Iterum Therapeutics plc in 2026.

Earnings calendar

Next earnings date

—

Not scheduled

EPS estimate

—

Revenue estimate

—

Past earnings

30 Mar 2026
EPS actual
—
estimate -0.15
Revenue actual
—
estimate 505.0K
Price reaction
1d
+2.37%
5d
-2.41%
30d
+4.37%
Sign in to view returns
18 Mar 2026
EPS actual
—
estimate -0.15
Revenue actual
—
estimate 505.0K
Price reaction
1d
+2.37%
5d
-2.41%
30d
+4.37%
Sign in to view returns
14 Nov 2025
EPS actual
-0.16 (-77.8%)
estimate -0.09
Revenue actual
390.0K
estimate 0
Price reaction
1d
+2.37%
5d
-2.41%
30d
+4.37%
Sign in to view returns
Beat Miss usd

Dividend calendar

No dividend history available.

EPS (Earnings Per Share)

Revenue

Company profile

Iterum Therapeutics plc, a clinical-stage pharmaceutical company, engages in developing and commercializing anti-infectives in Ireland, Bermuda, and the United States. It is developing sulopenem, a novel anti-infective compound with oral and IV formulations that is in Phase III clinical trials for the treatment of uncomplicated urinary tract infections, complicated urinary tract infections, and complicated intra-abdominal infections. The company was incorporated in 2015 and is headquartered in Dublin, Ireland.

Sector
Healthcare
Industry
Biotechnology
Country
Ireland
Exchange
Nasdaq
CEO
Corey N. Fishman
Employees
9
IPO date
25 May 2018
ISIN
IE000TTOOBX0
Website
iterumtx.com

Frequently asked questions

What was Iterum Therapeutics plc's most recent earnings date?

Iterum Therapeutics plc (ITRM) last reported earnings on March 30, 2026.

Where is Iterum Therapeutics plc stock listed?

Iterum Therapeutics plc (ITRM) is listed on Nasdaq.